Could the Sasang constitution itself be a risk factor of abdominal obesity?

BMC Complementary and Alternative Medicine

Volumn 13, Issue , 2013, Pages

  Jang, Eunsu ^a   Baek, Younghwa ^a   Park, Kihyun ^a   Lee, Siwoo ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Abdominal obesity; Prevalence; Risk factor; Sasang constitutional medicine; Waist circumference

Indexed keywords

ABDOMINAL OBESITY; ADULT; ARTICLE; BODY CONSTITUTION; BODY HEIGHT; BODY WEIGHT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; KOREA; KOREAN MEDICINE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; SASANG CONSTITUTIONAL MEDICINE; SEX DIFFERENCE; WAIST CIRCUMFERENCE;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MEDICINE, KOREAN TRADITIONAL; MIDDLE AGED; OBESITY, ABDOMINAL; REPUBLIC OF KOREA; RISK FACTORS;

EID: 84875521783     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-13-72     Document Type: Article

References (36)

1. Haslam DW, James WP. Obesity. Lance 2005, 366(9492):1197-1209.
2. Sim KW, Lee SH, Lee HS. The relationship between body mass index and morbidity in Korea. Korean J Obesity 2001, 10(2):147-155.
3. Kannel WB, Adrienne Cupples L, Ramaswami R, Stokes J, Kreger BE, Higgins M. Regional obesity and risk of cardiovascular disease; the Framingham Study. J Clin Epidemiol 1991, 44(2):183-190. 10.1016/0895-4356(91)90265-B, 1995775.
4. Bouchard C, Bray GA, Hubbard VS. Basic and clinical aspects of regional fat distribution. Am J Clin Nutr 1990, 52(5):946.
5. Prineas RJ, Folsom AR, Kaye SA. Central adiposity and increased risk of coronary artery disease mortality in older women. Ann Epidemiol 1993, 3(1):35-41.
6. Detection EPO Evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285(19):2486-2497. 10.1001/jama.285.19.2486, 11368702, Detection EPO.
7. Fujimoto WY, Bergstrom RW, Boyko EJ, Leonetti DL, Newell-Morris LL, Wahl PW. Susceptibility to development of central adiposity among populations. Obes Res 2012, 3(Suppl 2):179-186.
8. WHO Obesity: preventing and managing the global epidemic. World Health Organization technical report series no. 894 2000, Geneva; Switzerland: World Health Organization, WHO.
9. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC. Diagnosis and management of the metabolic syndrome. Circulation 2005, 112(17):2735-2752. 10.1161/CIRCULATIONAHA.105.169404, 16157765.
10. WHO 2008-2013 action plan for the global strategy for the prevention and control of noncommunicable diseases 2008, 42. Geneva; Switzerland: World Health Organization, WHO.
11. Elliott SS, Keim NL, Stern JS, Teff K, Havel PJ. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 2002, 76(5):911-922.
12. Perez-Pozo S, Schold J, Nakagawa T, Sanchez-Lozada L, Johnson R, Lillo JL. Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes 2009, 34(3):454-461.
13. Choi ME. The not-so-sweet side of fructose. J Am Soc Nephrol 2009, 20(3):457-459. 10.1681/ASN.2009010104, 19244571.
14. Rosmond R, Bouchard C, Björntorp P. 5-HT2A receptor gene promoter polymorphism in relation to abdominal obesity and cortisol. Obes Res 2012, 10(7):585-589.
15. Rosmond R, Chagnon YC, Holm G, Chagnon M, Pérusse L, Lindell K, Carlsson B, Bouchard C, Björntorp P. A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis. Obes Res 2012, 8(3):211-218.
16. Lee JM. Longevity and life preservation in oriental medicine 1996, Seoul, Korea: Kyung Hee Univ. Press.
17. Kim JY, Pham DD. Sasang constitutional medicine as a holistic tailored medicine. Evid-Based Complementary Altern Med 2009, 6(Suppl 1):11-19.
18. Shim EB, Lee S, Kim JY, Earm YE. Physiome and sasang constitutional medicine. J Physiol Sci 2008, 58(7):433-440. 10.2170/physiolsci.RV004208, 18928639.
19. Lee T, Lee S, Choe B, Song I. A study on the prevalences of chronic diseases according to Sasang constitution at a health examination center. J Sasang Constitut Med 2005, 17(2):32-45.
20. Lee TG, Koh B, Lee S. Sasang constitution as a risk factor for diabetes mellitus: a cross-sectional study. Evid-Based Complementary Altern Med 2009, 6(1):99-103.
21. Lee J, Lee E, Yoo J, Kim Y, Koh B. The sasang constitutional types can act as a risk factor for hypertension. Clin Exp Hypertens 2011, 33(8):525-532. 10.3109/10641963.2011.561901, 21958429.
22. Choi K, Lee J, Yoo J, Lee E, Koh B. Sasang constitutional types can act as a risk factor for insulin resistance. Diabetes Res Clin Pract 2011, 91(3):e57-e60. 10.1016/j.diabres.2010.11.017, 21146241.
23. Song KH, Yu SG, Kim JY. Prevalence of metabolic syndrome according to Sasang constitutional medicine in Korean subjects. Evid-Based Complementary Altern Med 2012, 2012:646794.
24. Lee MK, Jang ES, Sohn HY, Park JY, Koh BH, Sung J, Kim JI, Kim JY, Seo JS. Investigation of genetic evidence for Sasang constitution types in South Korea. Genomics & Informatics 2009, 7(2):107-110. 10.5808/GI.2009.7.2.107, 23613975.
25. Won HH, Lee S, Jang E, Kim KK, Park YK, Kim YJ, Kim YS, Kim BY, Kim JY, Kim JW. A genome-wide scan for the sasang constitution in a korean family suggests significant linkage at chromosomes 8q11. 22-23 and 11q22. 1-3. J Altern Complement Med 2009, 15(7):765-769. 10.1089/acm.2009.0067, 19552595.
26. Jang E, Kim JY, Lee H, Kim H, Baek Y, Lee S. A Study on the reliability of Sasang constitutional body trunk measurement. Evid-Based Complementary Altern Med 2011, 2012:604842.
27. Song KH, Yu SG, Cha S, Kim JY. Association of the apolipoprotein A5 gene - 1131 T > C polymorphism with serum lipids in Korean subjects: impact of Sasang constitution. Evid-Based Complementary Altern Med 2011, 2012:598394.
28. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006, 444(7121):881-887. 10.1038/nature05488, 17167477.
29. Sánchez-Castillo CP, Velásquez-Monroy O, Lara-Esqueda A, Berber A, Sepulveda J, Tapia-Conyer R, T James WP. Diabetes and hypertension increases in a society with abdominal obesity: results of the Mexican National Health Survey 2000. Public Health Nutr 2005, 8(01):53-60. 10.1079/PHN2005659, 15707539.
30. KIOM Development of Diagnostic and Herbal Drug System based on Traditional Constitutional Korean Medicine 2007, Daejeon; Korea: Korea Institute of Oriental Medicine, KIOM.
31. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003, 42(6):1206-1252. 10.1161/01.HYP.0000107251.49515.c2, 14656957.
32. Association AD. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(Suppl 1):62-69.
33. WHO The Asia-Pacific perspective: redefining obesity and its treatment 2000, Geneva; Switzerland: World Health Organization, WHO.
34. Cha S, Koo I, Park BL, Jeong S, Choi SM, Kim KS, Shin HD, Kim JY. Genetic Effects of FTO and MC4R Polymorphisms on Body Mass in Constitutional Types. Evid-Based Complementary Altern Med 2011, 2011.
35. Kim JW, Jeon SH, Sull YK, Kim KK, Lee EJ. A study on the body shape classified by Sasang constitutions and gender using physical measurements. J Sasang Constitut Med 2006, 18(1):54-61.
36. KCDC The Third Korea National Health and Nutrition Examination Survey (KNHANES III) 2005 Health Examination 2006, Gwacheon; Korea: Korea Centers for Disease Control and Prevention, KCDC.